Ecot, Richard C.

HRN: 21-40-03  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/30/2022
06/06/2022
IV
600mg
Q 8H
Abscess, Ant Chest, L
Waiting Final Action 

Indication:      Type of Infection:      Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: